Show simple item record

dc.contributor.authorAdams, Clive E.
dc.date.accessioned2017-10-30T10:39:19Z
dc.date.available2017-10-30T10:39:19Z
dc.date.issued2008
dc.identifier.citationSheriff, R. J. S., Adams, C. E., Tharyan, P., Jayaram, M. & Duley, L. (2008). Randomised trials relevant to mental health conducted in low and middle-income countries: A survey. BMC Psychiatry, 8 (69).en
dc.identifier.urihttp://hdl.handle.net/20.500.12904/9139
dc.description© Sheriff et al; licensee BioMed Central Ltd. 2008 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.description.abstractBackground: A substantial proportion of the psychiatric burden of disease falls on the world's poorest nations, yet relatively little is known about randomised trials conducted in these countries. Our aim was to identify and describe a representative sample of mental health trials from low and middle-income countries. Methods: 6107 electronic records, most with full text copies, were available following extensive searches for randomised or potentially randomised trials from low and middle-income countries published in 1991, 1995 and 2000. These records were searched to identify studies relevant to mental health. Data on study characteristics were extracted from the full text copies. Results: Trials relevant to mental health were reported in only 3% of the records. 176 records reporting 177 trials were identified: 25 were published in 1991, 45 in 1995, and 106 in 2000. Participants from China were represented in 46% of trials described. 68% of trials had <100 participants. The method of sequence generation was described in less than 20% of reports and adequate concealment of allocation was described in only 12% of reports. Participants were most frequently adults with unipolar depression (36/177) or schizophrenia (36/177). 80% of studies evaluated pharmacological interventions, a third of which were not listed by WHO as essential drugs. 41% of reports were indexed on PubMed; this proportion decreased from 68% in 1991 to 32% in 2000. Conclusion: In terms of overall health burden, trial research activity from low and middle-income countries in mental health appears to be low, and in no area adequately reflects need. (PsycINFO Database Record (c) 2016 APA, all rights reserved) (Source: journal abstract)
dc.description.urihttps://bmcpsychiatry.biomedcentral.com/articles/10.1186/1471-244X-8-69
dc.formatFull text uploaded
dc.subjectDeveloping countriesen
dc.subjectMental disordersen
dc.subjectMental health servicesen
dc.subjectSocioeconomic factorsen
dc.subjectSurveys and questionnairesen
dc.subjectMental healthen
dc.titleRandomised trials relevant to mental health conducted in low and middle-income countries: A surveyen
dc.typeArticle
refterms.dateFOA2021-06-14T10:38:24Z
html.description.abstractBackground: A substantial proportion of the psychiatric burden of disease falls on the world's poorest nations, yet relatively little is known about randomised trials conducted in these countries. Our aim was to identify and describe a representative sample of mental health trials from low and middle-income countries. Methods: 6107 electronic records, most with full text copies, were available following extensive searches for randomised or potentially randomised trials from low and middle-income countries published in 1991, 1995 and 2000. These records were searched to identify studies relevant to mental health. Data on study characteristics were extracted from the full text copies. Results: Trials relevant to mental health were reported in only 3% of the records. 176 records reporting 177 trials were identified: 25 were published in 1991, 45 in 1995, and 106 in 2000. Participants from China were represented in 46% of trials described. 68% of trials had <100 participants. The method of sequence generation was described in less than 20% of reports and adequate concealment of allocation was described in only 12% of reports. Participants were most frequently adults with unipolar depression (36/177) or schizophrenia (36/177). 80% of studies evaluated pharmacological interventions, a third of which were not listed by WHO as essential drugs. 41% of reports were indexed on PubMed; this proportion decreased from 68% in 1991 to 32% in 2000. Conclusion: In terms of overall health burden, trial research activity from low and middle-income countries in mental health appears to be low, and in no area adequately reflects need. (PsycINFO Database Record (c) 2016 APA, all rights reserved) (Source: journal abstract)


Files in this item

Thumbnail
Name:
Sheriff 2008 1-9.pdf
Size:
894.0Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record